Current opinion in neurologyHumansMeningiomaMeningeal NeoplasmsMolecular Targeted TherapyImmunotherapy
Emerging targeted therapies in meningiomas.
Erika Yamazawa, Emily Sullivan, Hiroaki Wakimoto, Priscilla K Brastianos
Published: 202510.1097/WCO.0000000000001430
Abstract
PURPOSE OF REVIEW: Patients with grade 2 and 3 meningioma have high recurrence rates and limited treatment options after failure of radiation and surgery. Recent advances in molecular profiling of these tumors have enabled the investigation of novel…
Preview only. Read the full abstract at the source